Literature DB >> 33297360

Mutations and Copy Number Alterations in IDH Wild-Type Glioblastomas Are Shaped by Different Oncogenic Mechanisms.

Ege Ülgen1, Sıla Karacan1, Umut Gerlevik1, Özge Can2, Kaya Bilguvar3,4, Yavuz Oktay5,6, Cemaliye B Akyerli7, Şirin K Yüksel7, Ayça E Danyeli8, Tarık Tihan9, O Uğur Sezerman1, M Cengiz Yakıcıer10, M Necmettin Pamir11, Koray Özduman11.   

Abstract

Little is known about the mutational processes that shape the genetic landscape of gliomas. Numerous mutational processes leave marks on the genome in the form of mutations, copy number alterations, rearrangements or their combinations. To explore gliomagenesis, we hypothesized that gliomas with different underlying oncogenic mechanisms would have differences in the burden of various forms of these genomic alterations. This was an analysis on adult diffuse gliomas, but IDH-mutant gliomas as well as diffuse midline gliomas H3-K27M were excluded to search for the possible presence of new entities among the very heterogenous group of IDH-WT glioblastomas. The cohort was divided into two molecular subsets: (1) Molecularly-defined GBM (mGBM) as those that carried molecular features of glioblastomas (including TERT promoter mutations, 7/10 pattern, or EGFR-amplification), and (2) those who did not (others). Whole exome sequencing was performed for 37 primary tumors and matched blood samples as well as 8 recurrences. Single nucleotide variations (SNV), short insertion or deletions (indels) and copy number alterations (CNA) were quantified using 5 quantitative metrics (SNV burden, indel burden, copy number alteration frequency-wGII, chromosomal arm event ratio-CAER, copy number amplitude) as well as 4 parameters that explored underlying oncogenic mechanisms (chromothripsis, double minutes, microsatellite instability and mutational signatures). Findings were validated in the TCGA pan-glioma cohort. mGBM and "Others" differed significantly in their SNV (only in the TCGA cohort) and CNA metrics but not indel burden. SNV burden increased with increasing age at diagnosis and at recurrences and was driven by mismatch repair deficiency. On the contrary, indel and CNA metrics remained stable over increasing age at diagnosis and with recurrences. Copy number alteration frequency (wGII) correlated significantly with chromothripsis while CAER and CN amplitude correlated significantly with the presence of double minutes, suggesting separate underlying mechanisms for different forms of CNA.

Entities:  

Keywords:  DNA repair; exome sequencing; glioma; mutational signatures

Year:  2020        PMID: 33297360      PMCID: PMC7762325          DOI: 10.3390/biomedicines8120574

Source DB:  PubMed          Journal:  Biomedicines        ISSN: 2227-9059


  45 in total

1.  Use of telomerase promoter mutations to mark specific molecular subsets with reciprocal clinical behavior in IDH mutant and IDH wild-type diffuse gliomas.

Authors:  Cemaliye B Akyerli; Şirin Yüksel; Özge Can; E Zeynep Erson-Omay; Yavuz Oktay; Erdal Coşgun; Ege Ülgen; Yiğit Erdemgil; Aydın Sav; Andreas von Deimling; Murat Günel; M Cengiz Yakıcıer; M Necmettin Pamir; Koray Özduman
Journal:  J Neurosurg       Date:  2017-06-16       Impact factor: 5.115

Review 2.  Double minutes in human tumor cells.

Authors:  P E Barker
Journal:  Cancer Genet Cytogenet       Date:  1982-02

3.  cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading.

Authors:  David N Louis; Pieter Wesseling; Kenneth Aldape; Daniel J Brat; David Capper; Ian A Cree; Charles Eberhart; Dominique Figarella-Branger; Maryam Fouladi; Gregory N Fuller; Caterina Giannini; Christine Haberler; Cynthia Hawkins; Takashi Komori; Johan M Kros; H K Ng; Brent A Orr; Sung-Hye Park; Werner Paulus; Arie Perry; Torsten Pietsch; Guido Reifenberger; Marc Rosenblum; Brian Rous; Felix Sahm; Chitra Sarkar; David A Solomon; Uri Tabori; Martin J van den Bent; Andreas von Deimling; Michael Weller; Valerie A White; David W Ellison
Journal:  Brain Pathol       Date:  2020-04-19       Impact factor: 6.508

4.  cIMPACT-NOW update 3: recommended diagnostic criteria for "Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV".

Authors:  Daniel J Brat; Kenneth Aldape; Howard Colman; Eric C Holland; David N Louis; Robert B Jenkins; B K Kleinschmidt-DeMasters; Arie Perry; Guido Reifenberger; Roger Stupp; Andreas von Deimling; Michael Weller
Journal:  Acta Neuropathol       Date:  2018-09-26       Impact factor: 17.088

5.  Distribution of EGFR amplification, combined chromosome 7 gain and chromosome 10 loss, and TERT promoter mutation in brain tumors and their potential for the reclassification of IDHwt astrocytoma to glioblastoma.

Authors:  Damian Stichel; Azadeh Ebrahimi; David Reuss; Daniel Schrimpf; Takahiro Ono; Mitsuaki Shirahata; Guido Reifenberger; Michael Weller; Daniel Hänggi; Wolfgang Wick; Christel Herold-Mende; Manfred Westphal; Sebastian Brandner; Stefan M Pfister; David Capper; Felix Sahm; Andreas von Deimling
Journal:  Acta Neuropathol       Date:  2018-09-05       Impact factor: 17.088

6.  Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma.

Authors:  Michele Ceccarelli; Floris P Barthel; Tathiane M Malta; Thais S Sabedot; Sofie R Salama; Bradley A Murray; Olena Morozova; Yulia Newton; Amie Radenbaugh; Stefano M Pagnotta; Samreen Anjum; Jiguang Wang; Ganiraju Manyam; Pietro Zoppoli; Shiyun Ling; Arjun A Rao; Mia Grifford; Andrew D Cherniack; Hailei Zhang; Laila Poisson; Carlos Gilberto Carlotti; Daniela Pretti da Cunha Tirapelli; Arvind Rao; Tom Mikkelsen; Ching C Lau; W K Alfred Yung; Raul Rabadan; Jason Huse; Daniel J Brat; Norman L Lehman; Jill S Barnholtz-Sloan; Siyuan Zheng; Kenneth Hess; Ganesh Rao; Matthew Meyerson; Rameen Beroukhim; Lee Cooper; Rehan Akbani; Margaret Wrensch; David Haussler; Kenneth D Aldape; Peter W Laird; David H Gutmann; Houtan Noushmehr; Antonio Iavarone; Roel G W Verhaak
Journal:  Cell       Date:  2016-01-28       Impact factor: 41.582

7.  Longitudinal analysis of treatment-induced genomic alterations in gliomas.

Authors:  E Zeynep Erson-Omay; Octavian Henegariu; S Bülent Omay; Akdes Serin Harmancı; Mark W Youngblood; Ketu Mishra-Gorur; Jie Li; Koray Özduman; Geneive Carrión-Grant; Victoria E Clark; Caner Çağlar; Mehmet Bakırcıoğlu; M Necmettin Pamir; Viviane Tabar; Alexander O Vortmeyer; Kaya Bilguvar; Katsuhito Yasuno; Lisa M DeAngelis; Joachim M Baehring; Jennifer Moliterno; Murat Günel
Journal:  Genome Med       Date:  2017-02-02       Impact factor: 11.117

8.  MSIpred: a python package for tumor microsatellite instability classification from tumor mutation annotation data using a support vector machine.

Authors:  Chen Wang; Chun Liang
Journal:  Sci Rep       Date:  2018-12-03       Impact factor: 4.379

9.  Mechanisms and therapeutic implications of hypermutation in gliomas.

Authors:  Mehdi Touat; Yvonne Y Li; Adam N Boynton; Liam F Spurr; J Bryan Iorgulescu; Craig L Bohrson; Isidro Cortes-Ciriano; Cristina Birzu; Jack E Geduldig; Kristine Pelton; Mary Jane Lim-Fat; Sangita Pal; Ruben Ferrer-Luna; Shakti H Ramkissoon; Frank Dubois; Charlotte Bellamy; Naomi Currimjee; Juliana Bonardi; Kenin Qian; Patricia Ho; Seth Malinowski; Leon Taquet; Robert E Jones; Aniket Shetty; Kin-Hoe Chow; Radwa Sharaf; Dean Pavlick; Lee A Albacker; Nadia Younan; Capucine Baldini; Maïté Verreault; Marine Giry; Erell Guillerm; Samy Ammari; Frédéric Beuvon; Karima Mokhtari; Agusti Alentorn; Caroline Dehais; Caroline Houillier; Florence Laigle-Donadey; Dimitri Psimaras; Eudocia Q Lee; Lakshmi Nayak; J Ricardo McFaline-Figueroa; Alexandre Carpentier; Philippe Cornu; Laurent Capelle; Bertrand Mathon; Jill S Barnholtz-Sloan; Arnab Chakravarti; Wenya Linda Bi; E Antonio Chiocca; Katie Pricola Fehnel; Sanda Alexandrescu; Susan N Chi; Daphne Haas-Kogan; Tracy T Batchelor; Garrett M Frampton; Brian M Alexander; Raymond Y Huang; Azra H Ligon; Florence Coulet; Jean-Yves Delattre; Khê Hoang-Xuan; David M Meredith; Sandro Santagata; Alex Duval; Marc Sanson; Andrew D Cherniack; Patrick Y Wen; David A Reardon; Aurélien Marabelle; Peter J Park; Ahmed Idbaih; Rameen Beroukhim; Pratiti Bandopadhayay; Franck Bielle; Keith L Ligon
Journal:  Nature       Date:  2020-04-15       Impact factor: 49.962

10.  The integrated landscape of driver genomic alterations in glioblastoma.

Authors:  Veronique Frattini; Vladimir Trifonov; Joseph Minhow Chan; Angelica Castano; Marie Lia; Francesco Abate; Stephen T Keir; Alan X Ji; Pietro Zoppoli; Francesco Niola; Carla Danussi; Igor Dolgalev; Paola Porrati; Serena Pellegatta; Adriana Heguy; Gaurav Gupta; David J Pisapia; Peter Canoll; Jeffrey N Bruce; Roger E McLendon; Hai Yan; Ken Aldape; Gaetano Finocchiaro; Tom Mikkelsen; Gilbert G Privé; Darell D Bigner; Anna Lasorella; Raul Rabadan; Antonio Iavarone
Journal:  Nat Genet       Date:  2013-08-05       Impact factor: 38.330

View more
  1 in total

Review 1.  Opposed Interplay between IDH1 Mutations and the WNT/β-Catenin Pathway: Added Information for Glioma Classification.

Authors:  Alexandre Vallée; Yves Lecarpentier; Jean-Noël Vallée
Journal:  Biomedicines       Date:  2021-05-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.